HEADER OXIDOREDUCTASE 10-FEB-96 1CPO TITLE CHLOROPEROXIDASE CAVEAT 1CPO XYS B 4 HAS WRONG CHIRALITY AT ATOM C2 XYS B 6 HAS WRONG CAVEAT 2 1CPO CHIRALITY AT ATOM C2 XYS A 748 HAS WRONG CHIRALITY AT ATOM CAVEAT 3 1CPO C2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHLOROPEROXIDASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CPO, CLP; COMPND 5 EC: 1.11.1.10 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LEPTOXYPHIUM FUMAGO; SOURCE 3 ORGANISM_TAXID: 5474; SOURCE 4 ATCC: 16373 KEYWDS HYDROGEN-PEROXIDE OXIDOREDUCTASE, HEME PEROXIDASE, HALOPEROXIDASE, KEYWDS 2 OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.SUNDARAMOORTHY,T.L.POULOS REVDAT 6 09-OCT-24 1CPO 1 HETSYN REVDAT 5 29-JUL-20 1CPO 1 CAVEAT COMPND REMARK HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 25-DEC-19 1CPO 1 SEQRES LINK REVDAT 3 13-JUL-11 1CPO 1 VERSN REVDAT 2 24-FEB-09 1CPO 1 VERSN REVDAT 1 12-FEB-97 1CPO 0 JRNL AUTH M.SUNDARAMOORTHY,J.TERNER,T.L.POULOS JRNL TITL THE CRYSTAL STRUCTURE OF CHLOROPEROXIDASE: A HEME JRNL TITL 2 PEROXIDASE--CYTOCHROME P450 FUNCTIONAL HYBRID. JRNL REF STRUCTURE V. 3 1367 1995 JRNL REFN ISSN 0969-2126 JRNL PMID 8747463 JRNL DOI 10.1016/S0969-2126(01)00274-X REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.SUNDARAMOORTHY,J.M.MAURO,A.M.SULLIVAN,J.TERNER,T.L.POULOS REMARK 1 TITL PRELIMINARY CRYSTALLOGRAPHIC ANALYSIS OF CHLOROPEROXIDASE REMARK 1 TITL 2 FROM CALDARIOMYCES FUMAGO REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 51 842 1995 REMARK 1 REFN ISSN 0907-4449 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 25373 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2316 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 282 REMARK 3 SOLVENT ATOMS : 179 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.557 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1CPO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000172462. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-APR-94 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5148 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XENGEN REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29366 REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.600 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.09 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.38700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.86450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.68150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.86450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.38700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.68150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 216 O5 NAG C 1 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 42 128.08 -38.51 REMARK 500 ALA A 102 -108.36 -134.49 REMARK 500 ASP A 149 -168.34 -107.62 REMARK 500 PRO A 220 43.18 -76.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 396 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 29 SG REMARK 620 2 HEM A 396 NA 96.4 REMARK 620 3 HEM A 396 NB 91.9 89.1 REMARK 620 4 HEM A 396 NC 91.4 172.1 91.1 REMARK 620 5 HEM A 396 ND 96.2 89.8 171.8 88.9 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A 301 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 104 OE2 REMARK 620 2 HIS A 105 O 82.5 REMARK 620 3 SER A 108 OG 178.3 99.2 REMARK 620 4 HEM A 396 O2A 100.5 83.3 79.5 REMARK 620 5 HOH A 802 O 87.0 164.7 91.3 87.7 REMARK 620 6 HOH A 803 O 90.2 95.5 89.9 169.0 95.6 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: HE1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: HEME PROXIMAL SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: HEM REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: HEME DISTAL SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: MN REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: MANGANESE BINDING SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: NG1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: N-GLYCOSYLATION SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: NG2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: N-GLYCOSYLATION SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: NG3 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: N-GLYCOSYLATION SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: OG1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: O-GLYCOSYLATION SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: OG2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: O-GLYCOSYLATION SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: OG3 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: O-GLYCOSYLATION SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: OG4 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: O-GLYCOSYLATION SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: OG5 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: O-GLYCOSYLATION SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: OG6 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: O-GLYCOSYLATION SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: OG7 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: O-GLYCOSYLATION SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: OG8 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: O-GLYCOSYLATION SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: OG9 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: O-GLYCOSYLATION SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: OGA REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: O-GLYCOSYLATION SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: OGB REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: O-GLYCOSYLATION SITE. REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE OF CARBOHYDRATES IS NOT KNOWN AND HENCE THE REMARK 999 SUGARS WERE MODELLED BASED ON THE SIZE AND SHAPE OF THE REMARK 999 ELECTRON DENSITY ENVELOPES. DBREF 1CPO A 1 298 UNP P04963 PRXC_CALFU 22 319 SEQRES 1 A 299 PCA GLU PRO GLY SER GLY ILE GLY TYR PRO TYR ASP ASN SEQRES 2 A 299 ASN THR LEU PRO TYR VAL ALA PRO GLY PRO THR ASP SER SEQRES 3 A 299 ARG ALA PRO CYS PRO ALA LEU ASN ALA LEU ALA ASN HIS SEQRES 4 A 299 GLY TYR ILE PRO HIS ASP GLY ARG ALA ILE SER ARG GLU SEQRES 5 A 299 THR LEU GLN ASN ALA PHE LEU ASN HIS MET GLY ILE ALA SEQRES 6 A 299 ASN SER VAL ILE GLU LEU ALA LEU THR ASN ALA PHE VAL SEQRES 7 A 299 VAL CYS GLU TYR VAL THR GLY SER ASP CYS GLY ASP SER SEQRES 8 A 299 LEU VAL ASN LEU THR LEU LEU ALA GLU PRO HIS ALA PHE SEQRES 9 A 299 GLU HIS ASP HIS SER PHE SER ARG LYS ASP TYR LYS GLN SEQRES 10 A 299 GLY VAL ALA ASN SER ASN ASP PHE ILE ASP ASN ARG ASN SEQRES 11 A 299 PHE ASP ALA GLU THR PHE GLN THR SER LEU ASP VAL VAL SEQRES 12 A 299 ALA GLY LYS THR HIS PHE ASP TYR ALA ASP MET ASN GLU SEQRES 13 A 299 ILE ARG LEU GLN ARG GLU SER LEU SER ASN GLU LEU ASP SEQRES 14 A 299 PHE PRO GLY TRP PHE THR GLU SER LYS PRO ILE GLN ASN SEQRES 15 A 299 VAL GLU SER GLY PHE ILE PHE ALA LEU VAL SER ASP PHE SEQRES 16 A 299 ASN LEU PRO ASP ASN ASP GLU ASN PRO LEU VAL ARG ILE SEQRES 17 A 299 ASP TRP TRP LYS TYR TRP PHE THR ASN GLU SER PHE PRO SEQRES 18 A 299 TYR HIS LEU GLY TRP HIS PRO PRO SER PRO ALA ARG GLU SEQRES 19 A 299 ILE GLU PHE VAL THR SER ALA SER SER ALA VAL LEU ALA SEQRES 20 A 299 ALA SER VAL THR SER THR PRO SER SER LEU PRO SER GLY SEQRES 21 A 299 ALA ILE GLY PRO GLY ALA GLU ALA VAL PRO LEU SER PHE SEQRES 22 A 299 ALA SER THR MET THR PRO PHE LEU LEU ALA THR ASN ALA SEQRES 23 A 299 PRO TYR TYR ALA GLN ASP PRO THR LEU GLY PRO ASN ASP MODRES 1CPO ASN A 12 ASN GLYCOSYLATION SITE MODRES 1CPO ASN A 93 ASN GLYCOSYLATION SITE MODRES 1CPO ASN A 216 ASN GLYCOSYLATION SITE MODRES 1CPO THR A 238 THR GLYCOSYLATION SITE MODRES 1CPO SER A 239 SER GLYCOSYLATION SITE MODRES 1CPO SER A 241 SER GLYCOSYLATION SITE MODRES 1CPO SER A 242 SER GLYCOSYLATION SITE MODRES 1CPO SER A 248 SER GLYCOSYLATION SITE MODRES 1CPO THR A 250 THR GLYCOSYLATION SITE MODRES 1CPO SER A 251 SER GLYCOSYLATION SITE MODRES 1CPO THR A 252 THR GLYCOSYLATION SITE MODRES 1CPO THR A 275 THR GLYCOSYLATION SITE MODRES 1CPO THR A 283 THR GLYCOSYLATION SITE MODRES 1CPO THR A 293 THR GLYCOSYLATION SITE MODRES 1CPO PCA A 0 GLN PYROGLUTAMIC ACID HET PCA A 0 8 HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET XYS B 4 9 HET MAN B 5 11 HET XYS B 6 9 HET NAG C 1 14 HET NAG C 2 14 HET MAN D 1 11 HET ARB D 2 9 HET NAG A 512 14 HET MAN A 738 11 HET MAN A 739 11 HET MAN A 741 11 HET MAN A 742 11 HET XYS A 748 9 HET MAN A 750 11 HET MAN A 751 11 HET MAN A 752 11 HET MAN A 783 11 HET MAN A 793 11 HET MN A 301 1 HET HEM A 396 43 HETNAM PCA PYROGLUTAMIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM XYS ALPHA-D-XYLOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM ARB BETA-L-ARABINOPYRANOSE HETNAM MN MANGANESE (II) ION HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN XYS ALPHA-D-XYLOSE; D-XYLOSE; XYLOSE; XYLOPYRANOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN ARB BETA-L-ARABINOSE; L-ARABINOSE; ARABINOSE HETSYN HEM HEME FORMUL 1 PCA C5 H7 N O3 FORMUL 2 NAG 5(C8 H15 N O6) FORMUL 2 BMA C6 H12 O6 FORMUL 2 XYS 3(C5 H10 O5) FORMUL 2 MAN 11(C6 H12 O6) FORMUL 4 ARB C5 H10 O5 FORMUL 16 MN MN 2+ FORMUL 17 HEM C34 H32 FE N4 O4 FORMUL 18 HOH *179(H2 O) HELIX 1 1 PRO A 30 ASN A 37 1 8 HELIX 2 2 ARG A 50 MET A 61 1 12 HELIX 3 3 ASN A 65 THR A 83 1 19 HELIX 4 4 THR A 95 ALA A 98 5 4 HELIX 5 5 ALA A 132 VAL A 142 1 11 HELIX 6 6 TYR A 150 LEU A 167 1 18 HELIX 7 7 LYS A 177 VAL A 191 1 15 HELIX 8 8 ILE A 207 ASN A 216 1 10 HELIX 9 9 TYR A 221 LEU A 223 5 3 HELIX 10 10 ILE A 234 ALA A 246 1 13 SHEET 1 S1 2 GLY A 45 ILE A 48 0 SHEET 2 S1 2 LEU A 91 LEU A 94 -1 N LEU A 94 O GLY A 45 SSBOND 1 CYS A 79 CYS A 87 1555 1555 2.04 LINK C PCA A 0 N GLU A 1 1555 1555 1.33 LINK ND2 ASN A 12 C1 NAG A 512 1555 1555 1.45 LINK ND2 ASN A 93 C1 NAG B 1 1555 1555 1.45 LINK ND2 ASN A 216 C1 NAG C 1 1555 1555 1.45 LINK OG1 THR A 238 C1 MAN A 738 1555 1555 1.41 LINK OG SER A 239 C1 MAN A 739 1555 1555 1.39 LINK OG SER A 241 C1 MAN A 741 1555 1555 1.43 LINK OG SER A 242 C1 MAN A 742 1555 1555 1.41 LINK OG SER A 248 C1 XYS A 748 1555 1555 1.42 LINK OG1 THR A 250 C1 MAN A 750 1555 1555 1.41 LINK OG SER A 251 C1 MAN A 751 1555 1555 1.40 LINK OG1 THR A 252 C1 MAN A 752 1555 1555 1.42 LINK OG1 THR A 275 C1 MAN D 1 1555 1555 1.43 LINK OG1 THR A 283 C1 MAN A 783 1555 1555 1.42 LINK OG1 THR A 293 C1 MAN A 793 1555 1555 1.42 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.41 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.42 LINK O6 BMA B 3 C1 XYS B 4 1555 1555 1.42 LINK O3 BMA B 3 C1 XYS B 6 1555 1555 1.42 LINK O3 XYS B 4 C1 MAN B 5 1555 1555 1.43 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.42 LINK O2 MAN D 1 C1 ARB D 2 1555 1555 1.45 LINK SG CYS A 29 FE HEM A 396 1555 1555 2.35 LINK OE2 GLU A 104 MN MN A 301 1555 1555 2.41 LINK O HIS A 105 MN MN A 301 1555 1555 2.27 LINK OG SER A 108 MN MN A 301 1555 1555 2.33 LINK MN MN A 301 O2A HEM A 396 1555 1555 2.36 LINK MN MN A 301 O HOH A 802 1555 1555 2.34 LINK MN MN A 301 O HOH A 803 1555 1555 2.35 CISPEP 1 TYR A 8 PRO A 9 0 0.25 CISPEP 2 SER A 229 PRO A 230 0 0.01 CISPEP 3 ASP A 291 PRO A 292 0 0.09 SITE 1 HE1 2 HEM A 396 CYS A 29 SITE 1 HEM 5 HEM A 396 GLU A 183 HIS A 105 PHE A 186 SITE 2 HEM 5 HOH A 801 SITE 1 MN 7 MN A 301 HEM A 396 GLU A 104 HIS A 105 SITE 2 MN 7 SER A 108 HOH A 802 HOH A 803 SITE 1 NG1 2 ASN A 12 NAG A 512 SITE 1 NG2 7 ASN A 93 NAG B 1 NAG B 2 BMA B 3 SITE 2 NG2 7 XYS B 6 XYS B 4 MAN B 5 SITE 1 NG3 3 ASN A 216 NAG C 1 NAG C 2 SITE 1 OG1 2 THR A 238 MAN A 738 SITE 1 OG2 2 SER A 239 MAN A 739 SITE 1 OG3 2 SER A 241 MAN A 741 SITE 1 OG4 2 SER A 242 MAN A 742 SITE 1 OG5 2 SER A 248 XYS A 748 SITE 1 OG6 2 THR A 250 MAN A 750 SITE 1 OG7 2 SER A 251 MAN A 751 SITE 1 OG8 2 THR A 252 MAN A 752 SITE 1 OG9 3 THR A 275 MAN D 1 ARB D 2 SITE 1 OGA 2 THR A 283 MAN A 783 SITE 1 OGB 2 THR A 293 MAN A 793 CRYST1 58.774 71.363 91.729 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017014 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014013 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010902 0.00000 HETATM 1 N PCA A 0 34.934 2.037 24.077 1.00 13.45 N HETATM 2 CA PCA A 0 34.979 2.646 25.418 1.00 16.42 C HETATM 3 CB PCA A 0 33.743 3.527 25.535 1.00 14.91 C HETATM 4 CG PCA A 0 33.500 3.885 24.078 1.00 14.59 C HETATM 5 CD PCA A 0 33.798 2.588 23.325 1.00 13.97 C HETATM 6 OE PCA A 0 33.821 2.583 22.080 1.00 16.40 O HETATM 7 C PCA A 0 34.993 1.573 26.504 1.00 17.46 C HETATM 8 O PCA A 0 34.557 0.447 26.280 1.00 17.84 O